Tardy Covid Vaccine Makers Under Fire for Trials in Developing Nations

(Bloomberg) -- Japanese drugmaker Shionogi & Co. sealed a deal to conduct a placebo-controlled trial of its Covid-19 vaccine in Vietnam and will be expanding it in the Philippines and other Southeast Asian countries, even as criticism of such tests mounts in the scientific community.

Related Keywords

Mexico ,Philippines ,Osaka ,Japan ,Seychelles ,Morocco ,China ,Vietnam ,Republic Of ,South Africa ,Mauritius ,Indonesia ,Pakistan ,Chinese ,Murtazaf Dhrolia ,Isao Teshirogi ,Xiamen Innovax ,Chuang Zhen ,Aasim Ahmad ,Us Pfizer Inc ,Bloomberg ,Shionogi Co ,Daiichi Sankyo Co ,Kidney Center ,World Health Organization ,Walvax Biotechnology Co ,Xiamen Innovax Biotech Co ,Moderna Inc ,Southeast Asian ,Walvax Biotechnology ,Xiamen Innovax Biotech ,Shionogi President ,Chief Executive Officer Isao Teshirogi ,Southeast Asia ,Bloomberg Vaccine ,Bloomberg News ,Daiichi Sankyo ,Alltop ,Business ,Cos ,Top ,Wwtop ,World ,Industries ,Asia ,Drg ,Hea ,Africa ,Asiatop ,Gentop ,Wwtopam ,Wwtopas ,Coronavir ,